domingo, 29 de enero de 2017

Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis. | AHRQ Patient Safety Network

Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis. | AHRQ Patient Safety Network



Danish mammography screening program: more early cancers found with questionable significance (possible overdiagnosis).

Ann Intern Med. 2017 Jan 10; [Epub ahead of print].

PSNet email header



  • Study
  •  
  • Published December 2016

Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis.



    The overuse of medical care is increasingly recognized as a patient safety issue. Overdiagnosis can result in unnecessary use of medical care, subjecting patients to greater risk of harm. For example, in the case of breast cancer, screening may detect lesions that are not clinically significant, leading to further testing and unnecessary procedures. This study examined the impact of mammography screening on a cohort of women in Denmark. Researchers found that screening was not associated with decreased incidence of advanced cancer but increased incidence of nonadvanced tumors and ductal carcinoma in situ; the rate of overdiagnosis was significant. An accompanying editorial discusses overdiagnosis in breast cancer.










    View More

    No hay comentarios: